Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1.
Transforming growth factor β1 (TGF-β1) is the pivotal pro-fibrogenic cytokine in hepatic fibrosis. Reducing the over-produced expression of TGF-β1 or blocking its signaling pathways is considered to be a promising therapeutic strategy for hepatic fibrosis. In this study, we evaluated the feasibility...
Enregistré dans:
Auteurs principaux: | Xiaobao Fan, Qiannan Zhang, Shuang Li, Yifei Lv, Houqiang Su, Huiping Jiang, Zhiming Hao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/007d329ef4d04654b1b3b8085e3a0f1c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
ENMD-1068 inhibits liver fibrosis through attenuation of TGF-β1/Smad2/3 signaling in mice
par: Quan Sun, et autres
Publié: (2017) -
Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice
par: Xiao Wang, et autres
Publié: (2018) -
Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
par: Chen-Hsueh Pai, et autres
Publié: (2020) -
Attenuation of oxidative damage-associated hepatotoxicity by piperine in CCl4-induced liver fibrosis
par: Adil Farooq Wali, et autres
Publié: (2021) -
TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice
par: Xiaolong Tu, et autres
Publié: (2017)